Cytokines in arthritis - The 'big numbers' move centre stage

Rheumatology

Volumn 47, Issue 1, 2008, Pages 8-12

  Gaston, J S H ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Cytokines; Dendritic cells; Spondyloarthritis; Th17

Indexed keywords

CYTOKINE;

ARTHRITIS; AUTOIMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENTERITIS; HELPER CELL; HUMAN; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; REVIEW; SIGNAL TRANSDUCTION; SPONDYLARTHRITIS; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ARTHRITIS, RHEUMATOID; CYTOKINES; DENDRITIC CELLS; HUMANS; SPONDYLARTHRITIS; T-LYMPHOCYTE SUBSETS;

EID: 37349052871     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem203     Document Type: Review

References (55)

1. Mosmann T, Cherwinski H, Bond M, Giedlin M, Coffman R. Two types of murine helper T cell clone. I. Definition according to profiles of activities and secreted proteins. J Immunol 1986;136:2348-57.
2. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994;91:8562-6.
3. Rudwaleit M, Siegert S, Yin Z et al. Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: Its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 2001;60:36-42.
4. Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233-40.
5. Park H, Li ZX, Yang XO et al. A distinct lineage of CD4T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6:1133-41.
6. Kikly K, Liu L, Na SQ, Sedgwick JD. The IL-23/Th(17)axis: Therapeutic targets for autoimmune inflammation. Curr Opin Immunol 2006;18:670-5.
7. Liang SC, Tan XY, Luxenberg DP et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006;203:2271-9.
8. Cua DJ, Sherlock J, Chen Y et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421:744-8.
9. Murphy CA, Langrish CL, Chen Y et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-42 in joint autoimmune inflammation. J Exp Med 2003;198:1951-7.
10. Cho ML, Kang JW, Moon YM et al. STAT3 and NF-kappa B signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J Immunol 2006;176:5652-61.
11. Hirota K, Hashimoto M, Yoshitomi H et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 2007;204:41-7.
12. Yao ZB, Painter SL, Fanslow WC et al. Human IL-17: A novel cytokine derived from T cells. J Immunol 1995;155:5483-6.
13. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004;21:467-76.
14. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 Family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-52.
15. Leibundgut-Landmann S, Gross O, Robinson MJ et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 2007;8:630-8.
16. Happel KI, Dubin PJ, Zheng M et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 2005;202:761-9.
17. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: An effector CD4T cell lineage with regulatory T cell ties. Immunity 2006;24:677-88.
18. Lubberts E, van den Bersselaar L, Oppers-Walgreen B et al. IL-17 promotes bone erosion in murine oollagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol 2003;170:2655-62.
19. Sato K, Suematsu A, Okamoto K et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006;203:2673-82.
20. Makiikola O, Nisslla M, Lehtinen K, Leirisalorepo M, Granfors K. IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis. Annals of the Rheumatic Dis 1995;54:631-5.
21. Repo H, Koivuranta-Vaara P, Leirisalo-Repo M. Polymorphonuclear leucocyte function and previous Yersinia arthritis: Correlation of enhanced superoxide production with late manifestations. Ann Rheum Dis 1988;47:452-7.
22. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006;24:179-89.
23. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector T(H)17 and regulatory T cells. Nature 2006;441: 235-8.
24. Mangan PR, Harrington LE, OQuinn DB et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006;441:231-4.
25. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 2006;203:1685-91.
26. Ivanov II, McKenzie BS, Zhou L et al. The orphan nuclear receptor ROR gamma t directs the differentiation program of proinflammatory IL-17(+) T helper cells. Cell 2006;126:1121-33.
27. Hoeve MA, Savage NDL, de Boer T et al. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol 2006;36:661-70.
28. Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005;5:521-31.
29. Kastelein RA, Hunter CA, Coa DJ. Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007;25: 221-42.
30. Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-3.
31. Neurath MF. IL-23: A master regulator in Crohn disease. Nat Med 2007;13:26-8.
32. Yen D, Cheung J, Scheerens H et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006;116:1310-6.
33. Uhlig HH, McKenzie BS, Hue S et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 2006;25:309-18.
34. Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 2000;118:1001-11.
35. Becker C, Domhoff H, Neufert C et al. Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J Immunol 2006;177:2760-4.
36. Netea MG, Azam T, Ferwerda G et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 2005;102:16309-14.
37. Joosten LAB, Netea MG, Kim SH et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006;103:3298-303.
38. Cagnard N, Letourneur F, Essabbani A et al. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur Cytokine Netw 2005;16:289-92.
39. Fort MM, Cheung J, Yen D et al. IL-25 induces IL-4 IL-5, and_ IL-13 and Th2-associated pathologies in vivo. Immunity 2001;15:985-95.
40. Owyang AM, Zaph C, Wilson EH et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med 2006;203:843-9.
41. Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 2004;113:1664-75.
42. Cargill M, Schrodi SJ, Chang M et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Human Genet 2007;80:273-90.
43. Chan JR, Blumenschein W, Murphy E et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 2006;203:2577-87.
44. Krueger GG, Langley RG, Leonardi C et al. A human interleukin-12/ 23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 2007;356:580-92.
45. Zheng Y, Danilenko DM, Valdez P et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007;445: 648-51.
46. Ikeuchi H, Kuroiwa T, Hiramatsu N et al. Expression of interleukin-22 in rheumatoid arthritis: Potential role as a proinflammatory cytokine. Arthritis Rheum 2005; 52:1037-46.
47. Kotake S, Udagawa N, Takahashi N et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999;103:1345-52.
48. Ziolkowska N, Koc A, Luszczykiewicz G et al. High levels of IL-17 in rheumatoid arthritis patients: IL- 15 triggers in vitro IL-17 production via cyclosporin A- sensitive mechanism. J Immunol 2000;164:2832-8.
49. Wendling D, Racadot E, Cedoz J-P, Dumoulin G. IL-17, Bmp-7 and bone remodelling in ankylosing spondylitis. Arthritis Rheum 2006;54(Suppl):1799, Abstract.
50. Re F, Strominger JL. Toll-like Receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001;276:37692-9.
51. Veldhoen M, Stockinger B, TGFbeta1, a Jack of all trades: The link with pro-inflammatory IL-17-producing T cells. Trends Immunol 2006;27:358-61.
52. Lohr J, Knoechel B, Wang JJ, Villarino AV, Abbas AK. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 2006;203:2785-91.
53. Jarvis LB, Matyszak MK, Duggleby RC, Goodall JC, Hall FC, Gaston JSH. Autoreactive human peripheral blood CD8(+) T, cells with a regulatory phenotype and function. Eur J Immunol 2005;35:2896-908.
54. Colbert RA. HLA-B27 misfolding: A solution to the spondyloarthropathy conundrum? Mol Med Today 2000;6:224-30.
55. Kollnberger S, Bird L, Sun MY et al. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum 2002;46:2972-82.